Your browser doesn't support javascript.
loading
Intravitreal triamcinolone for refractory diabetic clinically significant macular oedema
Esculapio. 2011; 7 (3): 19-22
in English | IMEMR | ID: emr-195427
ABSTRACT

Objective:

to determine long term effects on final visual outcome, macular fluorescein leakage and intraocular pressure after intravitreal injection of triamcinolone for treating refractory diabetic clinically significant macular oedema [CSMO]
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Esculapio Year: 2011

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Esculapio Year: 2011